MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia.
about
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia.
@en
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia.
@nl
type
label
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia.
@en
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia.
@nl
prefLabel
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia.
@en
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia.
@nl
P2093
P2860
P1433
P1476
MEF2C Phosphorylation Is Required for Chemotherapy Resistance in Acute Myeloid Leukemia
@en
P2093
Alex Kentsis
Andrei V Krivtsov
Anthony Letai
Ari Melnick
Barbara Spitzer
Casie Reed
Christina Y Yim
Conor O'Donnell
Crystal Stutzke
Elisa de Stanchina
P2860
P304
P356
10.1158/2159-8290.CD-17-1271
P577
2018-02-05T00:00:00Z